Sumeet Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 7:03 pm

Quick Insight

Sumeet Industries Ltd, operating in the textiles-manmade fibre sector, currently trades at a price of 110 with a market cap of 1,158 Cr. The high P/E ratio of 107 suggests an overvalued stock, while the low ROE and ROCE at 2.14% indicate poor profitability and efficiency. Additionally, the OPM stands at a meager 5.47%, reflecting challenges in cost management. With a net profit of 170 Cr and reserves of 52 Cr against borrowings of ₹99Cr, the company's financial health seems precarious. The low P/BV ratio of 0.34x further reinforces concerns about the stock's valuation. In light of these metrics, investors should exercise caution and conduct thorough due diligence before considering an investment in Sumeet Industries Ltd.

Competitors of Sumeet Industries Ltd

All Competitor Stocks of Sumeet Industries Ltd

Quarterly Result

Last Updated: August 20, 2025, 3:00 am

Below is a detailed analysis of the quarterly data for Sumeet Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 248.47 Cr.. The value appears strong and on an upward trend. It has increased from 243.02 Cr. (Mar 2025) to 248.47 Cr., marking an increase of 5.45 Cr..
• For Expenses, as of Jun 2025, the value is 234.87 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 236.88 Cr. (Mar 2025) to 234.87 Cr., marking a decrease of 2.01 Cr..
• For Operating Profit, as of Jun 2025, the value is 13.60 Cr.. The value appears strong and on an upward trend. It has increased from 6.14 Cr. (Mar 2025) to 13.60 Cr., marking an increase of 7.46 Cr..
• For OPM %, as of Jun 2025, the value is 5.47%. The value appears strong and on an upward trend. It has increased from 2.53% (Mar 2025) to 5.47%, marking an increase of 2.94%.
• For Other Income, as of Jun 2025, the value is 1.36 Cr.. The value appears to be declining and may need further review. It has decreased from 77.62 Cr. (Mar 2025) to 1.36 Cr., marking a decrease of 76.26 Cr..
• For Interest, as of Jun 2025, the value is 1.91 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.63 Cr. (Mar 2025) to 1.91 Cr., marking an increase of 0.28 Cr..
• For Depreciation, as of Jun 2025, the value is 5.07 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.12 Cr. (Mar 2025) to 5.07 Cr., marking a decrease of 0.05 Cr..
• For Profit before tax, as of Jun 2025, the value is 7.98 Cr.. The value appears to be declining and may need further review. It has decreased from 77.01 Cr. (Mar 2025) to 7.98 Cr., marking a decrease of 69.03 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 12.13% (Mar 2025) to 0.00%, marking a decrease of 12.13%.
• For Net Profit, as of Jun 2025, the value is 7.98 Cr.. The value appears to be declining and may need further review. It has decreased from 67.68 Cr. (Mar 2025) to 7.98 Cr., marking a decrease of 59.70 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.76. The value appears to be declining and may need further review. It has decreased from 6.43 (Mar 2025) to 0.76, marking a decrease of 5.67.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 7:02 pm

Balance Sheet

Last Updated: August 11, 2025, 2:52 pm

Below is a detailed analysis of the balance sheet data for Sumeet Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 105.00 Cr.. The value appears strong and on an upward trend. It has increased from 104.00 Cr. (Mar 2024) to 105.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 52.00 Cr.. The value appears strong and on an upward trend. It has increased from -280.00 Cr. (Mar 2024) to 52.00 Cr., marking an increase of 332.00 Cr..
• For Borrowings, as of Mar 2025, the value is 99.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 490.00 Cr. (Mar 2024) to 99.00 Cr., marking a decrease of 391.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 172.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 114.00 Cr. (Mar 2024) to 172.00 Cr., marking an increase of 58.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 428.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 428.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 142.00 Cr.. The value appears to be declining and may need further review. It has decreased from 161.00 Cr. (Mar 2024) to 142.00 Cr., marking a decrease of 19.00 Cr..
• For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
• For Investments, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 285.00 Cr.. The value appears strong and on an upward trend. It has increased from 267.00 Cr. (Mar 2024) to 285.00 Cr., marking an increase of 18.00 Cr..
• For Total Assets, as of Mar 2025, the value is 428.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 428.00 Cr..

However, the Borrowings (99.00 Cr.) are higher than the Reserves (52.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Sumeet Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 16.17. This value is within the healthy range. It has increased from -5.69 (Mar 24) to 16.17, marking an increase of 21.86.
• For Diluted EPS (Rs.), as of Mar 25, the value is 12.78. This value is within the healthy range. It has increased from -5.69 (Mar 24) to 12.78, marking an increase of 18.47.
• For Cash EPS (Rs.), as of Mar 25, the value is 14.34. This value is within the healthy range. It has increased from -3.39 (Mar 24) to 14.34, marking an increase of 17.73.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 13.90. It has increased from -17.25 (Mar 24) to 13.90, marking an increase of 31.15.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 13.90. It has increased from -17.25 (Mar 24) to 13.90, marking an increase of 31.15.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 75.29. It has decreased from 95.02 (Mar 24) to 75.29, marking a decrease of 19.73.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 2. It has increased from -3.81 (Mar 24) to 1.10, marking an increase of 4.91.
• For PBIT / Share (Rs.), as of Mar 25, the value is -0.45. This value is below the healthy minimum of 0. It has increased from -6.12 (Mar 24) to -0.45, marking an increase of 5.67.
• For PBT / Share (Rs.), as of Mar 25, the value is 13.48. This value is within the healthy range. It has increased from -6.12 (Mar 24) to 13.48, marking an increase of 19.60.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 12.78. This value is within the healthy range. It has increased from -5.69 (Mar 24) to 12.78, marking an increase of 18.47.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.78. This value is within the healthy range. It has increased from -5.69 (Mar 24) to 12.78, marking an increase of 18.47.
• For PBDIT Margin (%), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 10. It has increased from -4.01 (Mar 24) to 1.46, marking an increase of 5.47.
• For PBIT Margin (%), as of Mar 25, the value is -0.60. This value is below the healthy minimum of 10. It has increased from -6.44 (Mar 24) to -0.60, marking an increase of 5.84.
• For PBT Margin (%), as of Mar 25, the value is 17.89. This value is within the healthy range. It has increased from -6.44 (Mar 24) to 17.89, marking an increase of 24.33.
• For Net Profit Margin (%), as of Mar 25, the value is 16.96. This value exceeds the healthy maximum of 10. It has increased from -5.99 (Mar 24) to 16.96, marking an increase of 22.95.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 16.96. This value is within the healthy range. It has increased from -5.99 (Mar 24) to 16.96, marking an increase of 22.95.
• For Return on Networth / Equity (%), as of Mar 25, the value is 91.92. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 91.92, marking an increase of 91.92.
• For Return on Capital Employeed (%), as of Mar 25, the value is -2.34. This value is below the healthy minimum of 10. It has decreased from 61.75 (Mar 24) to -2.34, marking a decrease of 64.09.
• For Return On Assets (%), as of Mar 25, the value is 39.73. This value is within the healthy range. It has increased from -13.79 (Mar 24) to 39.73, marking an increase of 53.52.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.25. This value is within the healthy range. It has increased from -0.06 (Mar 24) to 0.25, marking an increase of 0.31.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.38. This value is within the healthy range. It has increased from -2.57 (Mar 24) to 0.38, marking an increase of 2.95.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.34. It has increased from 2.23 (Mar 24) to 2.34, marking an increase of 0.11.
• For Current Ratio (X), as of Mar 25, the value is 1.62. This value is within the healthy range. It has increased from 0.47 (Mar 24) to 1.62, marking an increase of 1.15.
• For Quick Ratio (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has increased from 0.28 (Mar 24) to 0.98, marking an increase of 0.70.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.77. This value is within the healthy range. It has decreased from 8.17 (Mar 24) to 7.77, marking a decrease of 0.40.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.09. This value is within the healthy range. It has increased from -2,184.52 (Mar 24) to 4.09, marking an increase of 2,188.61.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -4.30. This value is below the healthy minimum of 3. It has increased from -3,259.30 (Mar 24) to -4.30, marking an increase of 3,255.00.
• For Enterprise Value (Cr.), as of Mar 25, the value is 80.81. It has decreased from 494.90 (Mar 24) to 80.81, marking a decrease of 414.09.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.09. This value is below the healthy minimum of 1. It has decreased from 0.50 (Mar 24) to 0.09, marking a decrease of 0.41.
• For EV / EBITDA (X), as of Mar 25, the value is 6.48. This value is within the healthy range. It has increased from -12.52 (Mar 24) to 6.48, marking an increase of 19.00.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 1. It has increased from 0.02 (Mar 24) to 0.06, marking an increase of 0.04.
• For Price / BV (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has increased from -0.14 (Mar 24) to 0.34, marking an increase of 0.48.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 1. It has increased from 0.02 (Mar 24) to 0.06, marking an increase of 0.04.
• For EarningsYield, as of Mar 25, the value is 2.65. This value is below the healthy minimum of 5. It has increased from -2.28 (Mar 24) to 2.65, marking an increase of 4.93.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness